Day One Receives Orphan Designation from the European Commission for DAY101 for the Treatment of Glioma
SOUTH SAN FRANCISCO, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing...